Phantom Neuro CEO Connor Glass to Present during BioFuture™ 2025 [Yahoo! Finance]
Coya Therapeutics, Inc. (COYA)
Company Research
Source: Yahoo! Finance
Connor Glass, CEO and Founder of Phantom Neuro , the company delivering breakthrough advancements in human-machine interface, will be speaking on the mainstage of this year's BioFuture™ 2025 . The conference is hosted by Demy-Colton and held in New York City this October 13th through 15th Phantom Neuro The innovative healthcare startup will be on stage among the likes of biotech, pharma, digital medicine, TechBio, healthcare delivery, policy, and investment leaders, participating in an industry-wide discussion of how new policy, technology, and capital markets are reshaping the healthcare ecosystem. Events will be held at Cure, a Deerfield affiliate in health and life science innovation. Dr. Connor Glass , CEO and founder Phantom Neuro, will present during a Spotlight Panel, " Rewiring Minds: Breakthroughs in Brain & CNS Health" (Spotlight Panel 1B). More information: This panel will be held on Monday, October 13th, from 11:00 AM-12:00 PM It will be on the 12th Floor of Cure
Show less
Read more
Impact Snapshot
Event Time:
COYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COYA alerts
High impacting Coya Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
COYA
News
- Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials Conferences [Yahoo! Finance]Yahoo! Finance
- ReAlta Life Sciences Appoints Dr. Howard Berman as Executive ChairmanBusiness Wire
- Coya Therapeutics to Participate in Upcoming Investor Relations and Clinical Trials ConferencesBusiness Wire
- Coya Therapeutics (NASDAQ:COYA) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Coya Therapeutics (NASDAQ:COYA) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=COYA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street MarketBeat
COYA
Earnings
- 11/12/25 - Miss
COYA
Sec Filings
- 11/12/25 - Form 10-Q
- 11/12/25 - Form 8-K
- 10/27/25 - Form 8-K
- COYA's page on the SEC website